The prevalence of nonalcoholic fatty liver disease in the Americas

Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 2

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an alarming public health problem. The disease is one of the main causes of chronic liver disease worldwide and is directly linked to the increased prevalence of obesity and type 2 diabetes mellitus (T2DM) in the general population. The worldwide prevalence of NAFLD has been estimated at 20-30%, but the prevalence is unknown in the Americas because of a lack of epidemiological studies. However, given the trends in the prevalence of diabetes and obesity, the prevalence of NAFLD and its consequences are expected to increase in the near future. The aim of the present study is to present the current data on the prevalence of NAFLD in the Americas. We performed an electronic search of the main databases from January 2000 to September 2013 and identified 356 reports that were reviewed. We focused on the epidemiology and prevalence of known NAFLD risk factors including obesity, T2DM, and the metabolic syndrome (MS). The prevalence of the MS was highest in the United States, Mexico, Costa Rica, Puerto Rico, Chile, and Venezuela. In addition, Puerto Rico, Guyana, and Mexico have the highest prevalence of T2DM in the Americas, while USA has the most people with T2DM. In conclusion, the prevalence rates of NAFLD and obesity were highest in the United States, Belize, Barbados, and Mexico.

Authors and Affiliations

Jorge A. López-Velázquez, Karen V. Silva-Vidal, Guadalupe Ponciano-Rodríguez, Norberto C. Chávez-Tapia, Marco Arrese, Misael Uribe, Nahum Méndez-Sánchez

Keywords

Related Articles

Prevention of hepatocellular carcinoma: a concise review of contemporary issues

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading cause of cancer deaths in men. Due to differences in the prevalence of viral hepatitis, the incidence of HCC in low and middle income...

Hepatic hemodynamics and transient elastography in alcoholic foamy degeneration: report of 2 cases

Alcoholic liver disease (ALD) covers a wide spectrum of pathology ranging from fatty liver disease to acute steatohepatitis to cirrhosis and/or hepatocellular carcinoma. Alcoholic foamy degeneration (AFD) is an uncommon,...

Treatment of HCV infection in patients with cirrhosis

The treatment of patients with cirrhosis has the following purposes: to prevent the complications of the disease; to allow for the regression of cirrhosis; and to prevent reinfection in the graft in patients undergoing l...

Download PDF file
  • EP ID EP78372
  • DOI -
  • Views 123
  • Downloads 0

How To Cite

Jorge A. López-Velázquez, Karen V. Silva-Vidal, Guadalupe Ponciano-Rodríguez, Norberto C. Chávez-Tapia, Marco Arrese, Misael Uribe, Nahum Méndez-Sánchez (2014). The prevalence of nonalcoholic fatty liver disease in the Americas. Annals of Hepatology, 13(2), 166-178. https://europub.co.uk./articles/-A-78372